BC Legislature - Health Committee, 40th Parliament

Palliative care See Hospice and palliative care
Paramedics

Services in rural B.C. See Emergency services and paramedic services under British Columbia – Rural B.C.

Patient Voices Network See Patients, feedback on system under Health – Health care system
Patients See Health – Health care system
Paving the Road to Higher Performance: Benchmarking Provincial Health Systems See Report on provincial health care systems under Conference Board of Canada
Pensions

Health benefits and prescription drug coverage (Morgan, S.) 3:1305

Performance Anxiety in the Canadian Health Care System conference See Michael Smith Foundation for Health Research
PharmaCare program

Challenges and opportunities (Walman, B.) 4:1140

Comparison with programs in other jurisdictions See Coverage programs, comparisons among jurisdictions under Drugs – Prescription drugs

Costs and spending, factors and trends (Walman, B.) 4:1105-1110, 4:1120-1125, 4:1135-1140

Coverage See also particular diseases, drugs, population groups, etc.

amounts and deductible (Morgan, S.) 3:1250-1300

approval process for eligible drugs See Drug approval process below under this main heading

coverage for drugs of known benefit (Morgan, S.) 3:1310-1320

coverage plans See also Fair PharmaCare plan below under this main heading

(Walman, B.) 4:1105, 4:1115-1125

enhanced coverage for persons born before 1940 (Moneo, M.) 4:1115

formulary of eligible drugs See Formulary below under this main heading

income-based coverage and deductibles (Moneo, M.) 4:1115 (Walman, B.) 4:1110-1115

medical equipment and supplies (Walman, B.) 4:1105, 4:1135

regular, partial and limited coverage (Moneo, M.) 4:1130 (Walman, B.) 4:1135

scope (Walman, B.) 4:1100-1105, 4:1115-1120

Drug approval process See also Review process under Drugs – Prescription drugs

changes since 2009 (Walman, B.) 4:1045

decisions in 2012-13 (Hammell) 4:1145 (Walman, B.) 4:1055, 4:1145

drug benefit council See Drug Benefit Council

evaluation of health and cost factors (Letnick) 4:1155 (Walman, B.) 4:1155

implementation of decisions (Walman, B.) 4:1055

information and transparency (Letnick) 4:1155 (Walman, B.) 4:1045-1050, 4:1155-1200

national process See Review process, common drug review under Drugs – Prescription drugs

process (Hammell) 4:1145 (Walman, B.) 4:1040-1100, 4:1145

task force See Pharmaceutical Task Force

therapeutic reviews (Walman, B.) 4:1055

timeline (Walman, B.) 4:1045, 4:1055

website for patient input (Walman, B.) 4:1050-1055

Enrolment (Walman, B.) 4:1110, 4:1125

Expansion (Morgan, S.) 3:1310

Fair PharmaCare plan (Moneo, M.) 4:1115 (Morgan, S.) 3:1250, 3:1300-1305 (Walman, B.) 4:1110-1115, 4:1125

Formulary of eligible drugs

online formulary (Walman, B.) 4:1050

scope and excluded drugs (Walman, B.) 4:1040

Funding decisions and relationship to hospital services (Finegood, D.) 3:1515

Legislation See Pharmaceutical Services Act

Low-cost alternative drug program (Moneo, M.) 4:1130

PharmaNet information system (Walman, B.) 4:1135

Plans See Coverage plans; Fair PharmaCare plan above under this main heading

Programs in other jurisdictions See Coverage programs under Drugs – Prescription drugs; particular jurisdictions

Public engagement and information (Letnick) 4:1155 (Walman, B.) 4:1045-1055, 4:1110, 4:1155-1200

Reference drug program (Moneo, M.) 4:1130-1135

Reform (Darcy) 3:1320 (Letnick) 3:1325 (Morgan, S.) 3:1325-1335

Reform and public information (Morgan, S.) 3:1315-1325

Special authority program (Moneo, M.) 4:1145 (Walman, B.) 4:1135

Pharmaceutical industry

Detailers See Prescribers, education and information under Drugs – Prescription drugs

Investment in prescription drug research and development (Morgan, S.) 3:1335

Lobbying of MLAs (Bing) 3:1330 (Letnick) 3:1335 (Morgan, S.) 3:1335

Potential impact of European trade agreement See Canada–European Union Comprehensive Economic and Trade Agreement

Pharmaceutical Policy Research Collaboration

Website information (Morgan, S.) 3:1315

Pharmaceutical Services Act

Regulations (Moneo, M.) 4:1130 (Walman, B.) 4:1110

Pharmaceutical Task Force

Recommendations (Walman, B.) 4:1045

Pharmacists

Dispensing fees, inclusion in physician fees (Lee) 3:1320

Dispensing of prescription drugs See Dispensing of drugs under Drugs – Prescription drugs

Fees and services, coverage under PharmaCare program (Walman, B.) 4:1105, 4:1120-1125

Role in prevention of prescription fraud See Fraud prevention under Drugs – Prescription drugs

Scope of practice, expansion (Lee) 4:1140 (Walman, B.) 4:1140-1145

PharmaNet See PharmaCare program
Physicians

Demographics and hours of work (Bing) 3:1150 (Goldsmith, L.) 3:1150-1155 (Letnick) 3:1155

Dispensing of prescription drugs See Dispensing of drugs under Drugs – Prescription drugs

Family physicians

divisions of family practice, establishment (Davidson, H.) 4:0950

divisions of family practice, inclusion of nurse practitioners (Darcy) 4:1005 (Davidson, H.) 4:1005

integration of services with community-based services See Primary health care under Health – Health care system

Patient choice (Goldsmith, L.) 3:1055

Payment, government funding See Funding for physicians under Health – Health care funding

Payment models

direct billing and extra billing (Morgan, S.) 3:1245-1250

fee-for-service payment system (Davidson, H.) 4:0920

independent business model (Morgan, S.) 3:0915, 3:0935-0945, 3:1025-1030

interjurisdictional comparisons (Darcy) 2:1450 (Lee) 2:1450 (Letnick) 2:1450

response by physicians (Morgan, S.) 3:0935-0940, 3:1030, 3:1245-1250, 3:1330

Prescription of drugs See also Prescribers under Drugs – Prescription drugs

(Morgan, S.) 3:1325

Prescription of drugs, fraud prevention See Fraud prevention under Drugs – Prescription drugs

Prescription of drugs, telephone prescription (Darcy) 4:1150 (Walman, B.) 4:1150

Primary care physicians, patient attachment and continuity (Goldsmith, L.) 3:1105

Professional practice

business operations (Goldsmith, L.) 3:1050

clinics and facilities See Health – Health care facilities and hospitals

group practices and networks of practice (Goldsmith, L.) 3:1105

Recruitment in rural areas See Health care services, physician supply under British Columbia – Rural B.C.

Role in health care system (Bing) 3:1025 (Goldsmith, L.) 3:1055, 3:1130-1135, 3:1145 (Morgan, S.) 3:0945-0950, 3:1005, 3:1030

Services, coverage

medically necessary services See also Role in health care system above under this main heading

(Letnick) 3:1325 (Morgan, S.) 3:1325

Specialists See also Supply below under this main heading

(Goldsmith, L.) 3:1105

Supply

distribution See also Rural B.C., health care services, physician supply under British Columbia

(Bing) 3:1040

distribution, comparisons among jurisdictions (Anis, A.) 3:1400-1405

GP for Me program (Davidson, H.) 4:1000

number (Davidson, H.) 4:0915

specialists (Morgan, S.) 3:1000, 3:1245

supply (Bing) 3:1150 (Goldsmith, L.) 3:1130, 3:1155

Training

training (Bing) 3:1150 (Goldsmith, L.) 3:1155

training for medical students from rural communities (Conroy) 4:1010 (Davidson, H.) 4:0955 (Morgan, S.) 3:1005

Picard, André

Comments on health care legislation (Morgan, S.) 3:0935

Prescription drugs See Drugs – Prescription drugs; PharmaCare program
Primary health care See Health – Health care system
Private clinics See Health – Health care facilities and hospitals
Provincial Health Services Authority

Role and responsibilities (Davidson, H.) 4:0915

Psychiatric illness See Mental illness under Mental health